ARTICLE | Company News
Arbor Pharmaceuticals, Takeda sales and marketing update
September 23, 2013 7:00 AM UTC
Takeda granted Arbor's Arbor Pharmaceuticals Ireland Ltd. subsidiary exclusive rights to commercialize hypertension drugs Edarbi azilsartan medoxomil and Edarbyclor azilsartan medoxomil/chlorthalido...